Impact BioMedical, Inc.

IBOAMEX • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.45 USD
↗ 0.02 (4.84%)AT CLOSE (11:59 AM EDT)
0.44
↘ 0.01 (2.62%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
0.44
↘ 0.01 (2.62%)
🔴Market: CLOSED

Impact BioMedical, Inc. (IBO) trades at $0.45 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Aug 6, 2026.

Open?$0.43
High?$0.47
Low?$0.43
Prev. Close?$0.43
Volume?30.7K
Avg. Volume?48.8K
VWAP?$0.44
Rel. Volume?0.63x
Bid / Ask
Bid?$0.41 × 5.0K
Ask?$0.54 × 3.0K
Spread?$0.13
Midpoint?$0.48
Valuation & Ratios
Market Cap?46.4M
Shares Out?107.8M
Float?11.7M
Float %?10.9%
P/E Ratio?N/A
P/B Ratio?4.04
EPS?-$0.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Infectious Disease & Vaccines
Employees
8
Market Cap
46.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.impactbiomedinc.com
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
56
Piotroski F-Score?0/9Weak
Altman Z-Score?6.31Safe
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?4.76%Low
Short Interest?557.4K
Days to Cover?10.0
Free Float11.7M
Avg Daily Volume55.7K
Settlement Date2026-07-15
Financial Health
Current Ratio?0.22Weak
Quick Ratio?0.19Weak
Cash Ratio?0.01Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
44
4.04FAIR▾
P/S?
Peers
100
S&P
3
1,188.80HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-10.5CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,188.29HIGH▾
Returns & Efficiency
ROE?
S&P
3
-112.2%WEAK▾
ROA?
S&P
3
-75.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$46.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist